could soon help to improve the detection of Alzheimer's disease (AD) patients and ensure they get the crucial early treatment they need to
prevent the illness developing rapidly.
Scientists from the European PredictAD project have engineered a clinical
tool which is capable of comparing biomarkers of a patient and alerting doctors
to people who are at high risk of developing the brain condition.
Currently, patients are diagnosed via a subjective process that relies on
interviews with the patient's friends and family.
"The PredictAD tool provides a new option to support decision making by
providing objective information about the patient", says Professor Hilkka
Soininen, who led the study at the University of Eastern Finland.
Doctors explained that improved diagnosis of the condition could delay the
onset of dementia by up to five years and may halve the healthcare costs
associated with the illness.
According to the Alzheimer's Society, there are currently 750,000
individuals with dementia in the UK.
© Adfero Ltd
Alzheimer's treatment news : 16 December 2011